Peptide Schedule
Omberacetam (Noopept)Small moleculeNo amino acid sequence. Icon reflects category theme only.

Omberacetam (Noopept) Dosage Calculator

CognitiveOralResearch~15-20 min half-life

Omberacetam (Noopept, GVS-111) is a synthetic dipeptide nootropic developed in Russia as a cognitive enhancer and neuroprotective agent.

Increases BDNF and NGF expression in the hippocampus for improved neuroplasticityEnhances memory consolidation and retrievalNeuroprotective against oxidative stress and amyloid-beta toxicityReduces anxiety and improves emotional stability without sedation8 weeks on / 4 weeks off

10mcg · Daily

100500
0.0 units
100 units (1mL)
Concentration
0
mcg/mL
Draw Volume
< 0.001
mL
Syringe Units
< 0.1
units
Doses / Vial
0
doses

Summary: Add 0mL BAC water to your 10mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.

Cycle Planner

Oral or Sublingual. Typical beginner frequency: daily.

Omberacetam (Noopept) Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~15-20 min (plasma); active metabolite CPG persists longer
50%25%12.5%100%75%50%25%0%018m35m53m1h1hTime after injectionDose remaining
After 1 half-life (18m): 50% remainsAfter 2 half-lives (35m): 25% remainsAfter 3 half-lives (53m): 12.5% remains
At a 10mcg dose: 50% = 5mcg remaining after 18m. Recommended frequency: 3x Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Omberacetam (Noopept) Dosing Protocol

LevelDose / InjectionFrequency
Beginner10mgDaily
Moderate10mg3x Daily
Aggressive20mg3x Daily

Note: Oral dipeptide nootropic (GVS-111). Piracetam-derived but ~1000x more potent by weight. Increases BDNF and NGF expression in hippocampus. Approved in Russia as a prescription nootropic. Take on an empty stomach for best absorption.

About Omberacetam (Noopept)

Omberacetam (Noopept, GVS-111) is a synthetic dipeptide nootropic developed in Russia as a cognitive enhancer and neuroprotective agent. Chemically known as N-phenylacetyl-L-prolylglycine ethyl ester, it was designed as a bioavailable prodrug that rapidly crosses the blood-brain barrier after oral administration. Though structurally related to piracetam, omberacetam is estimated to be roughly 1000 times more potent by weight. It acts primarily through modulation of glutamatergic AMPA and NMDA receptors, upregulation of BDNF and NGF expression in the hippocampus, and antioxidant-mediated neuroprotection. Approved in Russia for mild cognitive disorders of vascular and traumatic origin, it has shown improvements in memory, attention, and emotional stability in clinical studies lasting up to 56 days.

Frequently Asked Questions